Coronary Flow in Patients With Myocardial Bridges, Coronary Fistulae in the Setting of Unstable Non-Obstructive

Niya E Semerdzhieva1, Stefan Denchev2

  • 1Emergency, National Heart Hospital, Sofia, BGR.

Cureus
|March 17, 2021
PubMed

Insights

In patients with acute coronary syndrome and non-obstructive coronary disease, epicardial coronary flow improved after glyceryl trinitrate, especially in those with myocardial bridges or coronary fistulae on calcium channel blockers.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Diagnostic Imaging

Background:

  • Acute coronary syndrome (ACS) in patients with non-obstructive coronary disease presents diagnostic challenges.
  • Myocardial bridges and coronary artery fistulae are congenital anomalies that can affect coronary flow.
  • Assessing epicardial coronary flow is crucial for understanding ACS pathophysiology in these patients.

Purpose of the Study:

  • To compare epicardial coronary flow in ACS patients with and without coronary anomalies (myocardial bridges, fistulae) before and after glyceryl trinitrate administration.
  • To evaluate the impact of anti-ischaemic therapy, specifically calcium channel blockers, on coronary flow response.

Main Methods:

  • Coronary angiography was performed on 88 ACS patients with coronary stenoses <50%.
  • Epicardial coronary flow was assessed using the corrected Thrombolysis in Myocardial Infarction frame count (cTFC) method.
  • Measurements were taken at baseline and after intracoronary infusion of 200 µg glyceryl trinitrate.

Main Results:

  • Myocardial bridges and coronary artery fistulae were present in 4.4% and 2.2% of ACS patients, respectively.
  • Sixty-two percent of patients exhibited slow contrast media progression (cTFC>25), indicating impaired coronary flow.
  • Coronary flow improved after glyceryl trinitrate, particularly in patients with myocardial bridges and to a lesser extent in those with fistulae.
  • The response to glyceryl trinitrate was most pronounced in patients on background calcium channel blocker therapy.

Conclusions:

  • Epicardial coronary flow in ACS patients with non-obstructive coronary disease and myocardial bridges shows improved impairment after glyceryl trinitrate.
  • Intracoronary glyceryl trinitrate is effective in improving coronary flow in ACS patients with coronary anomalies on calcium channel blockers.
  • These findings highlight the utility of assessing coronary flow dynamics in managing ACS patients with non-obstructive coronary artery disease and structural variants.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
114
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
5.4K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
165
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
265
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
79